TOPMed fasting insulin whole genome sequence analysis

Publications

Whole Genome Sequence Association Analysis of Fasting Glucose and Fasting Insulin Levels in Diverse Cohorts from the NHLBI TOPMed Program.
DiCorpo D, Gaynor SM, et al.
Commun Biol. 2022 Jul 28;5(1):756. doi: 10.1038/s42003-022-03702-4.
PMID: 35902682

Phenotypes

  • Fasting insulin adj BMI

Subjects

Subjects Cohort Ancestry
898 Genetics of Cardiometabolic Health in the Amish (Amish) European
2,712 Atherosclerosis Risk in Communities Study VTE cohort (ARIC) Mixed
424 Cleveland Clinic Atrial Fibrillation Study (CFS) Mixed
59 Cardiovascular Health Study (CHS) European
2,730 Framingham Heart Study (FHS) European
449 Genetic Studies of Atherosclerosis Risk (GeneSTAR) Mixed
806 Genetic Epidemiology Network of Arteriopathy (GENOA) African
806 Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) European
1,347 Hypertension Genetic Epidemiology Network (HyperGEN) African
2,310 Jackson Heart Study (JHS) African
3,648 Multi-Ethnic Study of Atherosclerosis (MESA) Mixed
660 Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk - San Antonio Family Studies (SAFS) Hispanic
914 Samoan Adiposity Study (Samoan) Samoan
5,449 Women's Health Initiative (WHI) Mixed

Project

TOPMed logo

The NHLBI Trans-Omics for Precision Medicine program (TOPMed) integrates whole-genome sequencing with other 'omics data to improve scientific understanding of heart, lung, blood, and sleep disorders.

 

Experiment summary

This study is part of the TOPMed project "Whole Genome Sequence Analysis of Fasting Glucose and Insulin in Individuals without Diabetes". Whole genome sequencing single variant analysis and rare variant analysis of fasting insulin was performed in 26,807 TOPMed participants.

Acknowledgments

The Analysis Commons was funded by R01HL131136. Whole genome sequencing (WGS) for the Trans-Omics in Precision Medicine (TOPMed) program was supported by the National Heart, Lung and Blood Institute (NHLBI). WGS was provided by the following sequencing centers: Broad Genomics (3R01HL121007-01S1); Baylor (3U54HG003273-12S2 / HHSN268201500015C); NWGC (HHSN268201600032I); Psomagen (3R01HL112064-04S1); Illumina (R01HL112064); NYGC (HHSN268201500016C). Centralized read mapping and genotype calling, along with variant quality metrics and filtering, were provided by the TOPMed Informatics Research Center (3R01HL-117626-02S1). Phenotype harmonization, data management, sample-identity QC, and general study coordination, were provided by the TOPMed Data Coordinating Center (3R01HL-120393-02S1). We gratefully acknowledge the studies and participants who provided biological samples and data for TOPMed. The contributions of the investigators of the NHLBI TOPMed Consortium are gratefully acknowledged.

Dataset ID
TOPMed_frz5b_pooled_FI_WGS